≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm, without specification of site

DOID EFO MESH SNOMED PheWeb

C3_SECONDARY_WITHOUT_SITESPEC

cancer: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Cause of death: ICD-10 C80
Cause of death: ICD-9 199
Cause of death: ICD-8 199
Cancer registry: Topography ICD-O-3 C80

770

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

770

diagram downward connector

Check minimum number of events None

770

diagram downward connector

Include endpoints None

770

diagram downward connector
C3_SECONDARY_WITHOUT_SITESPEC

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 770 264 506
Unadjusted prevalence (%) 0.22 0.13 0.32
Mean age at first event (years) 70.03 67.24 71.49

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_SECONDARY_WITHOUT_SITESPEC – Malignant neoplasm, without specification of site
GWS hits:

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm, without specification of site
after Malignant neoplasm, without specification of site

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm, without specification of site

↥